John

New opportunity for innovation capital investment

27.09.2023

Strengthening the efficiency of innovation and increasing innovation performance that leads to business returns are key issues for the expected competitiveness turnaround in our country. The latter is linked to how to enhance the role of venture capital in the innovation process, especially in its early stages. In June 2023, an essential regulation was introduced that significantly affects the functioning of venture capital: the Parliament decided that business angels and institutional investors investing in the pre-seed and seed phases can use a convertible instruments. Many hope that the new legal framework will boost to innovation capital investment. Essentially, investors can provide a loan to an unlisted company that is less than five years old and has not yet paid dividends, which can be converted into equity under certain conditions during a capital raise. This can be repeated several times within a year.

John

Genomate Health has joined CancerX

03.06.2023

Genomate Health and CancerX have recently joined forces to advance the fight against cancer by unleashing the power of digital innovation. The aim of this public-private partnership is to unite multiple stakeholders and innovators to create a future that's free of the burden of cancer. Through this partnership, Genomate Health and CancerX will work together to develop and implement cutting-edge digital solutions that empower oncologists to provide more personalized and effective cancer treatments. By leveraging the latest advancements in artificial intelligence and precision oncology, the partnership will help oncologists to make better, data-driven decisions about cancer treatment options.

John

Guidance means accuracy

31.01.2020


A randomized clinical trial was conducted to compare all three known static guided surgery protocols (pilot, partial, and full) with each other and with freehand surgery in terms of accuracy, under the same conditions. A total of 207 implants of the same brand and type were placed in 101 partially edentulous volunteers in need of implantation in the mandible or maxilla or both. All cases were digitally planned, and the comparison of the planned and actual implant positions was performed using a medical image analysis software with dedicated algorithms. As for the comparison that this study sought to perform, it can be said that the static guided approach significantly improves the accuracy of dental implant surgery as compared to freehand surgery.

John

Oncompass Medicine won the Digitaleurope competition

04.02.2021

Oncompass Medicine, the predecessor company of Genomate Inc won the Digitaleurope competition, so this year a Hungarian biotechnology company has become the continent’s most promising company. With the Future Unicorn Award, they award businesses that are expected to be Europe’s most valuable technology companies that make the most important technology companies. Oncompass Medicine has developed a new technology for the selection of targeted therapy for cancer patients. The Real-Time Oncology Treatment Calculator ranks personalized, targeted therapeutic options in 405 types of cancer in just 20 milliseconds.

John

Oncompass's results are praised by Ursula von der Leyen

10.02.2022

Ursula von der Leyen, the President of the European Commission, praised the achievements of Oncompass Medicine. In the summer of 2021, the Hungarian team at Oncompass Medicine made a significant scientific advancement in the field of precision oncology and cancer treatment. The experts were among the first to demonstrate the utility of artificial intelligence in the personalized application of targeted cancer therapies. The scientific results serving as evidence were published in the Precision Oncology journal. The calculator software developed by the company has already attracted attention at the European level. During the opening of the conference on European digital development, Ursula von der Leyen highlighted the work of Oncompass, founded by cancer researcher István Peták.